Ligand ID: H4C Drugbank ID: DB09166(Etizolam) Indication:Etizolam (marketed under the brand name Etilaam, Etizola, Sedekopan, Etizest, Pasaden or Depas) is a benzodiazepine analog. The etizolam molecule differs from a benzodiazepine in that the benzene ring has been replaced by a thiophene ring, making the drug a thienodiazepine. It possesses amnesic, anxiolytic, anticonvulsant, hypnotic, sedative and skeletal muscle relaxant properties. Etizolam is not authorized for medical use in the U.S. However, it currently remains unscheduled and is legal for research purposes. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 4C66_A_H4CA1168_0 (BROMODOMAIN-CONTAINING PROTEIN 4) | 1zv8 | E2 GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | GLN C 36VAL C 34LEU C 30LEU E 30ILE B 12 | 1.65A | 20.75 | None | ||
![]() | 4C66_A_H4CA1168_0 (BROMODOMAIN-CONTAINING PROTEIN 4) | 2beq | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | GLN B 936VAL B 934LEU B 930LEU C 930ILE D1161 | 1.70A | 14.40 | None | ||
![]() | 4C66_A_H4CA1168_0 (BROMODOMAIN-CONTAINING PROTEIN 4) | 2fav | REPLICASEPOLYPROTEIN 1AB(PP1AB) (ORF1AB) (SARSr-CoV) | 5 / 9 | GLN A 142VAL A 165LEU A 13LEU A 11ILE A 154 | 1.71A | 19.57 | None | ||
![]() | 4C66_A_H4CA1168_0 (BROMODOMAIN-CONTAINING PROTEIN 4) | 5x5f | S PROTEIN (MERS-CoV) | 5 / 9 | PRO A 903GLN A 927VAL A 934LEU A1033ASN A1132 | 1.38A | 5.81 | None | ||
![]() | 4C66_A_H4CA1168_0 (BROMODOMAIN-CONTAINING PROTEIN 4) | 6nus | NSP8 (SARSr-CoV) | 5 / 9 | GLN B 158VAL B 167LEU B 184LEU B 180ASN B 173 | 1.75A | 17.33 | None | ||
![]() | 4C66_A_H4CA1168_0 (BROMODOMAIN-CONTAINING PROTEIN 4) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 9 | PRO B 579GLN B 564VAL B 576LEU B 585LEU B 552 | 1.59A | 7.16 | None | ||
![]() | 4C66_A_H4CA1168_0 (BROMODOMAIN-CONTAINING PROTEIN 4) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 9 | PRO A 579GLN A 564VAL A 576LEU A 585LEU A 552 | 1.66A | 7.16 | None |